Golden Growers Coop GGROU Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Golden Growers Coop GGROU Company Overview 

Stock Message Board http://investorshangout.com/search?q=GGROU&am...mp;yt1=Go!

Golden Growers Coop GGROU Current Price and Quotes
6.25
Previous Close
6.25
Open
N/A

Daily Range
N/A - N/A
52wk Range
6.25 - 5.50

Volume
0
Dividend
N/A

Average Vol (3m)
8,000
Yield
N/A

Golden Growers Coop GGROU
Company Information
112 ROBERTS STREET
SUITE 111
FARGO, ND 58102

Phone: 701-281-0468

Golden Growers Coop GGROU
Golden Growers Coop GGROU
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Jun 30, 2013 10-Q
CIK 0001489874
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification
Incorporated In: MN, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark C. Dillon EVP, CEO
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Golden Growers Coop GGROU
GGROU Security Details
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)


Golden Growers Coop GGROU Recent News

Golden Growers Coop GGROU Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 92,838 79,376 58,015 18,293
Cost of Revenue 92,935 79,478 58,114 18,300
Gross Profit (97) (102) (99) (7)
Operating Expenses
Research and Development - - - -
Sales, General and Admin. (5,735) (5,424) (5,081) (2,013)
Non-Recurring Items - - - -
Other - - - -
Operating Income 5,638 5,322 4,982 2,006
Income From Continuing Operations
Add'l Income/Expense Items 11 16 27 17
Earnings Before Interest and Tax 5,649 5,338 5,009 2,023
Interest Expense - - - -
Earnings Before Tax 5,649 5,338 5,009 2,023
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 5,649 5,338 5,009 2,023
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 5,649 5,338 5,009 2,023
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 5,649 5,338 5,009 2,023

GGROU Golden Growers Coop Research DD Guide

GGROU Golden Growers Coop Stock Message Board http://investorshangout.com/search?q=GGROU&am...mp;yt0=Go!
GGROU Golden Growers Coop Stock Quote http://www.otcmarkets.com/stock/GGROU/quote
GGROU Golden Growers Coop Stock Chart http://www.otcmarkets.com/stock/GGROU/chart
GGROU Golden Growers Coop Company Info http://www.otcmarkets.com/stock/GGROU/company-info
GGROU Golden Growers Coop Recent News http://www.otcmarkets.com/stock/GGROU/news
GGROU Golden Growers Coop Financials http://www.otcmarkets.com/stock/GGROU/financials
GGROU Golden Growers Coop Filings and Disclosure http://www.otcmarkets.com/stock/GGROU/filings
GGROU Golden Growers Coop Short Sales http://www.otcmarkets.com/stock/GGROU/short-sales
GGROU Golden Growers Coop Insider Disclosure http://www.otcmarkets.com/stock/GGROU/insider-transactions
GGROU Golden Growers Coop Research Reports http://www.otcmarkets.com/stock/GGROU/research
GGROU Golden Growers Coop Summary http://finance.yahoo.com/q?s=GGROU
GGROU Golden Growers Coop Historical Prices http://finance.yahoo.com/q/hp?s=GGROU+Historical+Prices
GGROU Golden Growers Coop Interactive Chart http://finance.yahoo.com/echarts?s=GGROU
GGROU Golden Growers Coop Basic Chart http://finance.yahoo.com/q/bc?s=GGROU+Basic+Chart
GGROU Golden Growers Coop Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GGROU+Basic+Tech.+Analysis
GGROU Golden Growers Coop Headlines http://finance.yahoo.com/q/h?s=GGROU+Headlines
GGROU Golden Growers Coop Press Releases http://finance.yahoo.com/q/p?s=GGROU+Press+Releases
GGROU Golden Growers Coop Company Profile http://finance.yahoo.com/q/pr?s=GGROU+Profile
GGROU Golden Growers Coop Key Statistics http://finance.yahoo.com/q/ks?s=GGROU+Key+Statistics
GGROU Golden Growers Coop Industry http://finance.yahoo.com/q/in?s=GGROU+Industry
GGROU Golden Growers Coop Major Holders http://finance.yahoo.com/q/mh?s=GGROU+Major+Holders
GGROU Golden Growers Coop Insider Transactions http://finance.yahoo.com/q/it?s=GGROU+Insider+Transactions
GGROU Golden Growers Coop Insider Roster http://finance.yahoo.com/q/ir?s=GGROU+Insider+Roster
GGROU Golden Growers Coop Income Statement http://finance.yahoo.com/q/is?s=GGROU
GGROU Golden Growers Coop Balance Sheet http://finance.yahoo.com/q/bs?s=GGROU
GGROU Golden Growers Coop Cash Flow http://finance.yahoo.com/q/cf?s=GGROU+Cash+Flow&annual
GGROU Golden Growers Coop Nasdaq http://www.nasdaq.com/symbol/GGROU
GGROU Golden Growers Coop Market Watch http://www.marketwatch.com/investing/stock/GGROU
GGROU Golden Growers Coop Bloomberg http://www.bloomberg.com/quote/GGROU:US
GGROU Golden Growers Coop Morningstar http://quotes.morningstar.com/stock/s?t=GGROU
GGROU Golden Growers Coop Bussinessweek http://investing.businessweek.com/research/st...cker=GGROU
GGROU Golden Growers Coop Barchart http://www.barchart.com/quotes/stocks/GGROU
GGROU Golden Growers Coop OTC Short Report http://otcshortreport.com/index.php?index=GGROU
GGROU Golden Growers Coop Investopedia http://www.investopedia.com/markets/stocks/GGROU/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Deadline Looms for Insulet Lawsuit Investors

Updated Category News Views 25

Tick Tock: Investors, Your Clock's Running Out We're not talking about your everyday hiccup here. Insulet Corporation (NASDAQ: PODD) investors have some major decisions to make fast. If there's one deadline you can't afford to sleep through, it's the one coming up on August 31, 2026. That's when folks who've taken a hit investing in Insulet are up to their necks in legal...

Continue Reading
Essential Strategies for Staying Cool This Summer on a Budget

Updated Category News Views 149

Essential Strategies for Staying Cool This Summer on a Budget C & C Heating & Air Conditioning emphasizes a comprehensive approach to reducing energy consumption and maintaining sustainability. C & C Heating & Air Conditioning, a renowned heating and cooling service provider with over seventy years of industry experience, suggests that homeowners can enjoy a cooler...

Continue Reading
F.N.B. Corporation Announces Quarterly Dividend of $0.12

Updated Category News Views 151

F.N.B. Corporation Dividend Announcement F.N.B. Corporation (NYSE: FNB) has officially announced the declaration of a quarterly cash dividend, set at $0.12 per share for its common stock. This move reflects the corporation's strong commitment to rewarding its shareholders and maintaining a solid financial foundation. Details of the Dividend Declaration The dividend is...

Continue Reading
Analyzing Visa's Competitive Edge in Financial Services

Updated Category News Views 231

Understanding Visa's Market Position In a world driven by financial innovation and fierce competition, it's essential for investors and enthusiasts to closely examine the players in the financial services sector. This article delves into Visa (NYSE: V) and contrasts its performance against that of its main competitors. By looking at crucial financial metrics, market...

Continue Reading
Ethereum's Staking Revolution: New Opportunities Await Investors

Updated Category News Views 187

Ethereum's Remarkable Growth and Staking Potential The digital currency scene is buzzing with excitement as Ethereum spot ETFs have recorded impressive weekly inflows reaching $515 million, a notable first in history. This surge in investment highlights Ethereum's growing reputation as a reliable asset favored alike by institutional and retail investors. The Impact of...

Continue Reading